Federal Quantum Funding Boosts D-Wave's Prospects but Execution Risk Remains

What happened

The U.S. Department of Commerce's $2 billion quantum computing injection, with $100 million earmarked for D-Wave, follows on the heels of D-Wave's Q1'26 bookings of $33.4M, including a $20M system sale and $10M enterprise QCaaS agreement. While the funding validates the government's commitment to the space and could ease D-Wave's liquidity concerns, the company disclosed that the $100M CHIPS Act LOI is conditional on issuing $100M in common shares, introducing material dilution risk. D-Wave's Q1'26 revenue fell to $2.9M from $15.0M a year ago, highlighting the disconnect between bookings and recognized revenue, even as RPO grew to $42.4M. The stock's move to $29.40 (up 124% from May 2025) reflects optimistic assumptions about RPO conversion and federal support, but the WAIT rating remains appropriate until there is concrete evidence of revenue step-up without per-share value leakage.

Implication

Over the next 6-12 months, the CHIPS award and RPO conversion are key catalysts. If FAU installation commences by end-2026 and quarterly revenue exceeds $10M, upside to $42 is possible. But if CHIPS terms force dilutive equity issuance or revenue conversion stalls, the downside to $18 remains real.

Thesis delta

The federal funding is a positive but expected tailwind that does not meaningfully alter the risk/reward calculus. The thesis remains WAIT with conviction 4.0: upside requires visible revenue step-ups and on-time FAU installation, while downside is triggered by conversion delays or dilutive financing. The CHIPS LOI's share-issuance condition reinforces the dilution risk already embedded in the bear case.